Trial no.:
|
PACTR202508726005103 |
Date of Registration:
|
14/08/2025 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Laparoscopic-Assisted Hydrostatic Reduction for Pediatric Intussusception |
Official scientific title |
Laparoscopic-Assisted Hydrostatic Reduction of Pediatric Intussusception: A Prospective Study from a Single Tertiary Center |
Brief summary describing the background
and objectives of the trial
|
Intussusception is a leading cause of bowel obstruction in the pediatric population. Its diagnosis is usually based on clinical features and is confirmed either by Ultrasonography (U/S) or contrast enema, Computed Tomography (CT) scan is considered on rare occasions. Approximately 85% of these cases are reduced via pneumatic or hydrostatic enema.
Radiological guided reduction of intussusception (air or saline enema) is considered the first line of treatment with an average success rate 80% (range 40%-90%). Surgical intervention is required for the cases with failed enema reduction, hemodynamic instability and/or peritonitis. This typically involves 10 to 20% of cases. Traditionally, unsuccessful radiological reduction has been followed by laparotomy.
Later, the introduction of laparoscopy in pediatric surgical field has added another dimension to the management of intussusception. The use of laparoscopy has increased significantly in the past 20 years. It was initially utilized as a diagnostic modality after failed hydrostatic reduction of intussusception and then was used as a definitive treatment.
Available reports claim advantages of laparoscopic over the open approach, such as less postoperative pain, reduced wound complications, minimal scarring, shorter hospital stay and an earlier return to normal activities.
The purpose of this study was to evaluate the benefit of laparoscopy in guiding hydrostatic reduction of intussusception and evaluation of the reduced mass with regard to perforation, ischemic signs or any other pathology. |
Type of trial |
Observational |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Digestive System,Paediatrics,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
01/01/2023 |
Actual trial start date |
01/01/2023 |
Anticipated date of last follow up |
31/12/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
53 |
Actual target sample size (number of participants) |
53 |
Recruitment status |
Completed |
Publication URL |
|
|